Advanced search×

Synthesis and DNA cleavage activity of 2-hydrazinyl-1,4,5,6-tetrahydropyrimidine containing hydroxy group

Bioorg Med Chem 17(13):6 (2009) PMID 19481940

2-Hydrazinyl-1,4,5,6-tetrahydropyrimidin-5-ol dihydrochloride 2, as well as 2-hydrazinyl-4,5-dihydro-1H-imidazole dihydrochloride 1, was synthesized as metal-free DNA cleaving agent. Agarose gel electrophoresis was used to assess the plasmid pUC 19 DNA cleavage activities in the presence of 1 and 2. DNA cleavage efficiency of 2 exhibits remarkable increases compared with its corresponding non-hydroxy compound 1. Kinetic data of DNA cleavage promoted by 2 fit to the Michaelis-Menten-type equation with k"m"a"x of 0.0378+/-0.0013h^-^1 giving 10^6-fold rate acceleration over uncatalyzed DNA. The acceleration is driven by the spatial proximity of the nucleophilic hydroxy group and the electrophilic activation for the phosphodiester by the ammonium and/or guanidinium groups. In vitro cytotoxic activities toward Hela cells and human leukemia HL-60 cells were also examined, and 2 exhibits stronger cytotoxic activities than 1.

DOI: 10.1016/j.bmc.2009.05.044
Version: za2963e q8za2 q8zb1 q8zc2 q8zd8 q8ze4 q8zf9 q8zg4

Similar articles you may find interesting…

  1. Editorial board
    Author(s) unavailable

    Bioorg Med Chem 17(13):0 (2009)

  2. [Synthesis of ologonucleotides on a popcorn-polystyrene polymeric carrier].

    Justus Liebigs Ann Chem (1972) PMID 4652949

  3. RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes

    Eur J Pharmacol 652(1-3):7 (2011) PMID 20540938

    Dipeptidyl peptidase IV (DPP-IV) inhibiton is a well recognized approach to treat Type 2 diabetes. RBx-0597 is a novel DPP-IV inhibitor discovered in our laboratory. The aim of the present study was to characterize the pharmacological profiles of RBx-0597 in vitro and in vivo as an anti-diabetic age...